Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-13-001748
Filing Date
2013-11-14
Accepted
2013-11-14 14:40:51
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2013-09-30 aoxing.htm 10-Q 517945
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh311.htm EX-31.1 9368
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh312.htm EX-31.2 8838
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh321.htm EX-32.1 5566
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh322.htm EX-32.2 4972
  Complete submission text file 0001096906-13-001748.txt   2940833

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT** axn-20130930.xml EX-101.INS 399273
7 XBRL SCHEMA DOCUMENT** axn-20130930.xsd EX-101.SCH 27251
8 XBRL CALCULATION LINKBASE DOCUMENT** axn-20130930_cal.xml EX-101.CAL 25991
9 XBRL DEFINITION LINKBASE DOCUMENT** axn-20130930_def.xml EX-101.DEF 31454
10 XBRL LABELS LINKBASE DOCUMENT** axn-20130930_lab.xml EX-101.LAB 133039
11 XBRL PRESENTATION LINKBASE DOCUMENT** axn-20130930_pre.xml EX-101.PRE 121574
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 131219131
SIC: 2834 Pharmaceutical Preparations